KRKA: 2024 Krka Group Performance Estimate

opublikowano: 2025-01-30 12:00

Spis treści:

1. REPORT

2. INFORMATION ABOUT THE ENTITY

3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY


Spis załączników:
Krka_Group_2024_Performance_Estimate.pdf  (REPORT)

POLISH FINANCIAL SUPERVISION AUTHORITY
UNI - EN REPORT No 4 / 2025
Date of issue: 2025-01-30
Short name of the issuer
KRKA
Subject
2024 Krka Group Performance Estimate
Official market - legal basis
art. 17. 1 MAR.
Unofficial market - legal basis
Contents of the report:
Based on the provisions of Article 26 of the Ljubljana Stock Exchange Rules, Article 158 of the Market in Financial Instruments Act, and Article 17 of Regulation (EU) No 596/2014, Krka, d. d., Novo mesto (hereinafter: Krka) releases the 2024 unaudited performance estimates for the Krka Group.

The press releases with 2024 Krka Group performance estimate is attached.

This announcement will be published on the company’s website (www.krka.biz) starting from 30 January 2025, for a minimum period of 5 years.
Annexes
File Description
Krka Group 2024 Performance Estimate.pdfKrka Group 2024 Performance Estimate.pdf Krka Group 2024 Performance Estimate

KRKA, TOVARNA ZDRAVIL D.D.
(fullname of the issuer)
KRKA Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
8501 Nove Mesto
(post code) (city)
Smarjeska 6
(street) (number)
+386 7 331 21 11 +386 7 332 15 37
(phone number) (fax)
(e-mail) (web site)
nie dotyczy
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2025-01-30 Jože Colarič President of the Management Board and CEO